Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
01/2015
01/21/2015CN102858763B 脯氨酰羟化酶抑制剂及其使用方法 Prolyl hydroxylase inhibitors and methods of use
01/21/2015CN102858341B 用于谷物中的真菌控制的含有5-氟胞核嘧啶的协同增效的杀真菌组合物 Fungicidal compositions for cereals containing 5-fluoro-cytosine synergistic control of fungi
01/21/2015CN102846609B 抗高血压药物伊拉地平的合成及其制剂 Synthesis of anti-hypertensive drugs and preparations isradipine
01/21/2015CN102813931B 一种壳聚糖纳米粒子及其制备方法和用途 Chitosan nanoparticles and their preparation and use
01/21/2015CN102807514B 取代的苯二胺类衍生物及其制备方法和用途 Two amine-substituted benzene derivatives and their preparation and use
01/21/2015CN102787158B 一种发酵法生产天然β-胡萝卜素的方法和应用 A fermented natural β- carotene production methods and applications
01/21/2015CN102781448B 用于治疗病毒性疾病的组合物和方法 Compositions and methods for the treatment of viral diseases
01/21/2015CN102781239B 使用拉喹莫德治疗狼疮关节炎 Use laquinimod treatment of lupus arthritis
01/21/2015CN102775371B 一种取代噻二嗪类衍生物及其制备方法与应用 Thiadiazines one substituted derivatives and its preparation method and application
01/21/2015CN102743363B 和厚朴酚及其衍生物制备治疗马拉色菌引起皮肤疾病的制品的用途 Honokiol and its derivatives prepared by the treatment of skin diseases caused by Malassezia use articles
01/21/2015CN102724977B 富里酸与氟康唑或两性霉素b组合用于真菌感染的治疗 Fulvic acid treatment with fluconazole or amphotericin b combination for fungal infections
01/21/2015CN102688244B 头孢噻肟钠和舒巴坦钠的复方制剂及其制备方法和应用 Compound and its preparation method and application of cefotaxime sodium and sulbactam sodium
01/21/2015CN102670532B 伊潘立酮药物组合物及其制备方法 Iloperidone pharmaceutical compositions and methods for preparing
01/21/2015CN102643241B 化合物和组合物以及使用方法 The compounds and compositions and the use of the method
01/21/2015CN102631354B 含维生素d3和二甲双胍的药物组合物 Pharmaceutical compositions containing vitamin d3 and metformin
01/21/2015CN102596917B 2-(4-((2-氨基-4-甲基-6-(戊基氨基)嘧啶-5-基)甲基)苯基)乙酸4-(二甲基氨基)丁酯的二糖精盐、二富马酸盐、二-(1-羟基-萘-2-甲酸)盐和单苯甲酸盐 2- (4 - ((2-amino-4-methyl-6- (pentyl-amino) pyrimidin-5-yl) methyl) phenyl) acetic acid 4- (dimethylamino) butyl disaccharide salt , two fumarate, di - (1-hydroxy - 2-carboxylic acid) salts and single benzoate
01/21/2015CN102596202B 吡嘧司特的晶形 Pemirolast crystalline form
01/21/2015CN102584756B 新颖紫红曲酮、其制备方法及紫红曲酮的用途 New purple naltrexone, their preparation and use of naltrexone purple
01/21/2015CN102574853B 杂环肟化合物 Heterocyclic compounds oxime
01/21/2015CN102574842B 用于抑制pi3激酶的吡啶基咪唑酮衍生物 Pyridyl imidazole for inhibiting pi3 kinase ketone derivative
01/21/2015CN102525879B 制备阿瑞匹坦固体分散组合物的方法 Preparation of aprepitant solid dispersion method of compositions
01/21/2015CN102482218B 作为蛋白激酶调节剂的吡啶和吡嗪衍生物 Pyridine and pyrazine derivatives as modulators of protein kinase
01/21/2015CN102480952B 抗菌剂 Antibacterial agents
01/21/2015CN102423342B 防治皮肤湿疹和瘙痒症的药物组合物及剂型和应用 The pharmaceutical compositions and dosage forms and applications prevent skin eczema and pruritus
01/21/2015CN102415953B 一种具有除臭功能的药物组合物及其制备方法 The pharmaceutical composition and method for preparing a deodorant function
01/21/2015CN102414216B 1-(2'-氰基-2'-脱氧-β-D-阿拉伯呋喃糖基)胞嘧啶一盐酸盐的稳定型结晶 1- (2'-cyano-2'-deoxy -β-D- arabinofuranosyl) cytosine monohydrochloride stable crystalline
01/21/2015CN102406840B 一种肿痛凝胶膏剂及其制备方法 A swollen gel paste and preparation method
01/21/2015CN102382005B 含氨基羧酸酰胺结构的丙泊酚酯类衍生物、制备方法及其用途 Propofol ester derivatives containing amino acid amide structure, preparation and use
01/21/2015CN102327257B 氯桂丁胺缓释药物组合物 Gui butylamine chlorine release pharmaceutical composition
01/21/2015CN102304570B 用于癌症诊断和治疗的组合物和方法 Compositions and methods for diagnosis and treatment of cancer
01/21/2015CN102178677B 硝苯地平双层渗透泵药物组合物及其制备工艺 Nifedipine layer osmotic pump pharmaceutical compositions and preparation process
01/21/2015CN102133196B 离子结合组合物 Ion binding composition
01/21/2015CN102119156B 取代的吡咯及其使用方法 Substituted pyrrole and methods of use
01/21/2015CN102076362B 尼古丁锭剂组合物 Nicotine lozenge composition
01/21/2015CN101899041B 葛根素的一种优势药用晶型固体物质及制备方法与用途 An advantage of puerarin medicinal crystalline solids and preparation method and use
01/21/2015CN101820950B 作为刺猬蛋白信号通路调节剂的联苯基甲酰胺类化合物 As the hedgehog signaling pathway modulators biphenyl carboxamides
01/21/2015CN101816313B 中药卫生球 Medicine mothballs
01/21/2015CN101563078B 包含迷迭香酸的组合物, 其用途及制备方法 The composition contains rosmarinic acid, its use and its preparation method
01/21/2015CN101516194B 减轻神经元细胞损害的方法 Neuronal cell damage mitigation methods
01/20/2015US8937194 Topical compositions containing nitro fatty acids
01/20/2015US8937189 Tri-substituted 2-benzhydryl-5-benzylamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3,6-disubstituted pyran derivatives
01/20/2015US8937187 Method for depigmenting keratin materials using resorcinol derivatives
01/20/2015US8937181 Benzenesulfonamide compounds and the use thereof
01/20/2015US8937178 Phthalazinone compounds and methods for the treatment of cystic fibrosis
01/20/2015US8937167 Compounds and methods for treating bacterial infections
01/20/2015US8937156 Saposin C-DOPS: a novel anti-tumor agent
01/20/2015US8937150 Anti-viral compounds
01/20/2015US8937099 N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress
01/20/2015US8937098 Dermatological compositions comprising at least one naphthoic acid compound and at least one film-forming agent and treatment of keratinization disorders therewith
01/20/2015US8937097 Methods for purifying trans-(−)-Δ9-tetrahydrocannabinol and trans-(+)-Δ9-tetrahydrocannabinol
01/20/2015US8937096 Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
01/20/2015US8937094 Triazole compounds that modulate HSP90 activity
01/20/2015US8937093 Heterocyclic aspartyl protease inhibitors
01/20/2015US8937092 Aryl or N-heteroaryl substituted methanesulfonamide derivatives as vanilloid receptor ligands
01/20/2015US8937091 Inhibitor of protein crosslinking and use of the same
01/20/2015US8937090 Parakeratosis inhibitor, pore-shrinking agent and external composition for skin
01/20/2015US8937088 Ureas for the treatment and prevention of cancer
01/20/2015US8937086 Compounds for the treatment of pathologies associated with aging and degenerative disorders
01/20/2015US8937085 Pharmaceutical carrier composition and pharmaceutical composition
01/20/2015US8937084 Nitrogen containing morphinan derivatives and the use thereof
01/20/2015US8937083 Pesticidal compositions and processes related thereto
01/20/2015US8937082 Nilotinib salts and crystalline forms thereof
01/20/2015US8937080 Pyrimidine substituted macrocyclic HCV inhibitors
01/20/2015US8937079 Polymorph forms of 4-anilinoquinazoline derivatives, the preparation methods and uses thereof
01/20/2015US8937078 Quinazolinones as prolyl hydroxylase inhibitors
01/20/2015US8937077 Bicyclic diamines as janus kinase inhibitors
01/20/2015US8937076 Crystalline form of entecavir, its preparation and the pharmaceutical composition and uses thereof
01/20/2015US8937075 Thieno- and furo-pyrimidine modulators of the histamine H4 receptor
01/20/2015US8937074 Enhancement of the action of anti-infective agents and of central and peripheral nervous system agents and transportation of nucleic acid substances
01/20/2015US8937072 Substituted cyanoaniline compounds, preparation and use thereof
01/20/2015US8937070 Inhibitors of protein kinases
01/20/2015US8937069 Substituted pyrrolo[2,3-B]pyrazine compounds and their use
01/20/2015US8937068 Pyridopyrazine derivatives and their use
01/20/2015US8937067 Activators of human pyruvate kinase
01/20/2015US8937066 Amino derivatives of dihydro-1,3,5-triazine used in the treatment of ischemia and/or reperfusion related diseases
01/20/2015US8937065 Compositions and methods for modulating a kinase
01/20/2015US8937064 Pyrazolo[1,5-a]pyrimidines useful as JAK2 inhibitors
01/20/2015US8937063 Niacin mimetics, and methods of use thereof
01/20/2015US8937062 Compositions and methods for treating, reducing, ameliorating, or preventing infections caused by antibacterial drug-resistant bacteria
01/20/2015US8937061 Stereoselective total synthesis of noribogaine
01/20/2015US8937060 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders
01/20/2015US8937059 Method for enhancing folding and transport of misfolded glucocerebrosidase
01/20/2015US8937058 17-hydroxy-19-nor-21-carboxylic acid-steroid γ-lactone derivative, use thereof, and medicament containing the derivative
01/20/2015US8937057 Combination of azelastine and mometasone for nasal administration
01/20/2015US8937056 Multikinase inhibitors for use in the treatment of cancer
01/20/2015US8937055 Heterocyclic ring compound having muscle cell or adipocyte differentiation regulating action
01/20/2015US8937054 Liquid-fertilizer ready formulations of bifenthrin
01/20/2015US8937053 Process for the preparation of prasugrel and several novel crystalline forms of prasugrel hydrochloride
01/20/2015US8937052 Therapeutic protocols using hyaluronan
01/20/2015US8937050 Methods and compositions for treatment of autism
01/20/2015US8936942 Polyethyleneglycol-modified lipid compounds and uses thereof
01/20/2015US8936941 Compositions useful for cancer detection and treatment, a cancer stem cell model, and methods of production and use thereof
01/20/2015US8936907 Neural transfection reagents
01/20/2015US8936814 Skin cream
01/20/2015US8936813 Spray drying methods and related compositions
01/20/2015US8936812 Tamper-resistant oral opioid agonist formulations
01/20/2015US8936811 Device coated with glycogen particles comprising nucleic acid complexes
01/20/2015US8936809 Method for treating prostate diseases based on local delivery of active substances
01/20/2015US8936808 Opioid agonist/opioid antagonist/acetaminophen combinations
01/20/2015US8936804 Use of vanadium compounds to accelerate bone healing
1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 7860